Randomized phase II study with two gemcitabine- and docetaxel-based combinations as first-line chemotherapy for metastatic non-small cell lung cancer
Passardi Alessandro, Cecconetto Lorenzo, Dall'Agata Monia, Dazzi Claudio, Pasquini Enzo, Oliverio Giovanni, Zumaglini Federica, Zoli Wainer, Nanni Oriana, Milandri Carlo, Frassineti Giovanni, Amadori Dino